Highlight article: αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats

In chronic kidney disease (CKD), evidence suggests that soluble αKlotho (sKlotho) has cardioprotective effects. Contrariwise, high circulating levels of fibroblast growth factor 23 (FGF23) are related to uremic cardiomyopathy development. Recently, it has been demonstrated that sKlotho can act as a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Biol Med (Maywood)
Autors principals: Suassuna, Paulo Giovani de Albuquerque, Cherem, Paula Marocolo, de Castro, Bárbara Bruna, Maquigussa, Edgar, Cenedeze, Marco Antonio, Lovisi, Júlio Cesar Moraes, Custódio, Melani Ribeiro, Sanders-Pinheiro, Helady, de Paula, Rogério Baumgratz
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6987748/
https://ncbi.nlm.nih.gov/pubmed/31847589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219894302
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars